Tisch, Nathalie;López-Rivas, Abelardo;Freire-valls, Aida;Ruiz De Almodovar-Egea, Carmen;Yerbes-Cadenas, Rosario;Martín-Pérez, Rosa:
Journal of clinical investigation. Journal of Clinical Investigation. 2019. Vol: 129. Núm: 12. Pág. 5092-5107. 10.1172/JCI122767.
Schmitz, R;Schmidt, T;Freire-valls, Aida;Yerbes-Cadenas, Rosario;Von Richter , S;Kahlert , C;Loges , S;Weitz, J;Schneider, M;Ruiz De Almodovar, Carmen:
TAM receptors Tyro3 and Mer as novel targets in colorectal cancer. Oncotarget. 2017. Vol: 35. Pág. 56355-56370.
Martín-Pérez, Rosa;Yerbes-Cadenas, Rosario;Mora-molina, Rocío;Cano-González, Ana;Arribas, Joaquin;Mazzone, Massimiliano;López-Rivas, Abelardo;Palacios-Casanova, Maria Del Carmen:
Oncogenic p95Her2/611CTF primes human breast epithelial cells for metabolic stress-induced activation of TRAIL-R/Caspase-8-dependent apoptosis.. Oncotarget. 2017. Vol: 8. Pág. 93688-93703 . 10.18632/oncotarget.21458.
Chen, S;Martín-villalba, A;Tisch, N;Hermann, R;Yerbes-Cadenas, Rosario;M, Kegel;Hudalla, H;Zuliani, C;Gülcüler, Gs;Ruiz De Almodóvar , C:
CNS macrophages control neurovascular development via CD95L. Cell Reports. 2017. Vol: 17. Núm: 9. Pág. 13781393-1393.
Hanggi , K;Gough , Pj;Schmidt, T;Ruiz De Almodóvar, Carmen;Wong , Ww;Vasilikos, L;Freire-valls, Aida;Yerbes-Cadenas, Rosario;Knop, J;Spilgies, Lm;Riceck, K;Misra , T;Bertin , J:
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necrotic function. Cell Death & Disease. 2017. Vol: 8. Núm: 2. 10.1038/cddis.2017.20.
Palacios-Casanova, Maria Del Carmen;Yerbes-Cadenas, Rosario;Sánchez-Pérez, Tania;Martín-Pérez, Rosa;Cano-González, Ana;López-Rivas, Abelardo:
The long and winding road to cancer treatment: The TRAIL system. Current Pharmaceutical Design. 2014. Vol: 20. Pág. 2819-2833. 10.2174/13816128113199990588.
Martín-Pérez, Rosa;Palacios-Casanova, Maria Del Carmen;Yerbes-Cadenas, Rosario;Cano-González, Ana;López-Rivas, Abelardo:
Activated ERBB2/HER2 licenses sensitivity to apoptosis upon endoplasmic reticulum stress through a PERK-dependent pathway. Cancer Research. 2014. Vol: 74. Pág. 1766-1777.
Yerbes-Cadenas, Rosario;López-Rivas, Abelardo:
ITCH/AIP4-INDEPENDENT PROTEASOMAL DEGRADATION OF CFLIP MEDIATES SENSITIZATION OF BREAST TUMOR CELLS TO TRAIL BY THE HISTONE DEACETYLASE INHIBITOR SAHA. Investigational New Drugs. 2012. Vol: 30. Pág. 541-547. 10.1007/s10637-010-9597-x.
Yerbes-Cadenas, Rosario;López-Rivas, Abelardo;Reginato, Mauricio;Palacios-Casanova, Maria Del Carmen:
Control of FLIPL expression and TRAIL resistance by the extracellular signal-regulated kinase (ERK)1/2 pathway in breast epithelial cells . Cell Death and Differentiation. 2012. Vol: 19. Pág. 1908-1916.
Cano-González, Ana;Palacios-Casanova, Maria Del Carmen;Yerbes-Cadenas, Rosario;López-Rivas, Abelardo;Martín-Pérez, Rosa:
FEBS Journal. The FEBS Journal. 2012. Vol: 279.
Yerbes-Cadenas, Rosario;Palacios-Casanova, Maria Del Carmen;López-Rivas, Abelardo:
CELLULAR FLIPL PLAYS A SURVIVAL ROLE AND REGULATES MORPHOGENESIS IN BREAST EPITHELIAL CELLS. BIOCHEM. BIOPHYS. ACTA. 2011. Vol: 1813. Pág. 168-178. 10.1016/j.bbamcr.2010.10.003.
Yerbes-Cadenas, Rosario;Palacios-Casanova, Maria Del Carmen;López-Rivas, Abelardo:
The therapeutic potential of TRAIL receptor signalling in cancer cells. Clinical & Translational Oncology. 2011. Vol: 13. Núm: 12. Pág. 839-847. 10.1007/s12094-011-0744-4.
Ortiz-Ferron, Gustavo;Yerbes-Cadenas, Rosario;López-Pérez, Ana Isabel;López-Rivas, Abelardo:
ROSCOVITINE SENSITIZES BREAST CANCER CELLS TO TRAIL-INDUCED APOPTOSIS THROUGH A PLEIOTROPIC MECHANISM. Cell Research. 2008. Vol: 18. Núm: 6. Pág. 664-676.
Palacios-Casanova, Maria Del Carmen;Yerbes-Cadenas, Rosario;López-Rivas, Abelardo:
FLAVOPIRIDOL INDUCES CELLULAR FLICE-INHIBITORY PROTEIN DEGRADATION BY THE PROTEASOME AND PROMOTES TRAIL-INDUCED EARLY SIGNALING AND APOPTOSIS IN BREAS. Cancer Research. 2006. Vol: 66. Núm: 17. Pág. 8858-8869.